White Paper Development on Policy Landscape for Bio/Pharma Industry

Identify key trends and potential future approaches to oncology payment reform and provide detailed analysis and assessment on impact to client, as well as potential advocacy strategies against key threats.

Significant secondary and primary research with payors and oncologists, as well as Washington policy thoughtleaders.

• White paper document discussing key payment reform themes and specific tactics
• Rate and prioritize threats to Bio/Pharma industry
• Potential mitigation strategies and priorities

Senior executives, Policy groups

Use with leadership to inform advocacy priorities and budget.